^
Association details:
Evidence:
Evidence Level:
Resistant: C4 – Case Studies
New
Title:

Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F

Excerpt:
The ALK L1198F mutation was detected only in the lorlatinib-resistant specimen.
DOI:
10.1056/NEJMoa1508887